Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Hepatol Commun ; 7(3): e0045, 2023 03 01.
Article in English | MEDLINE | ID: mdl-36757426

ABSTRACT

Recent studies have suggested that sodium-glucose co-transporter2 inhibitors go beyond their glycemic advantages to ameliorate the development of NAFLD. However, little research has been done on the underlying mechanisms. Here, we took deep insight into the effect of canagliflozin (CANA), one of the sodium-glucose co-transporter2 inhibitor, on the progression of NAFLD, and explored the molecular mechanisms. Our findings showed that CANA-treated ob/ob and diabetic mice developed improved glucose and insulin tolerance, although their body weights were comparable or even increased compared with the controls. The CANA treatment ameliorated hepatic steatosis and lipid accumulation of free fatty acid-treated AML12 cells, accompanied by decreased lipogenic gene expression and increased fatty acid ß oxidation-related gene expression. Furthermore, inflammation and fibrosis genes decreased in the livers of CANA-treated ob/ob and diabetic mice mice. FGF21 and its downstream ERK1/2/AMPK signaling decreased, whereas NLRP3-mediated pyroptosis increased in the livers of the ob/ob and diabetic mice mice, which was reversed by the CANA treatment. In addition, blocking FGF21 or ERK1/2 activity antagonized the effects of CANA on NLRP3-mediated pyroptosis in lipopolysaccharide plus nigericin-treated J774A.1 cells. We conclude that CANA treatment alleviated insulin resistance and the progression of NAFLD in ob/ob and diabetic mice mice independent of the body weight change. CANA protected against the progression of NAFLD by inhibiting NLRP3-mediated pyroptosis and enhancing FGF21-ERK1/2 pathway activity in the liver. These findings suggest the therapeutic potential of sodium-glucose co-transporter2 inhibitors in the treatment of NAFLD.


Subject(s)
Diabetes Mellitus, Experimental , Non-alcoholic Fatty Liver Disease , Mice , Animals , Non-alcoholic Fatty Liver Disease/drug therapy , Non-alcoholic Fatty Liver Disease/complications , Canagliflozin/pharmacology , Canagliflozin/therapeutic use , NLR Family, Pyrin Domain-Containing 3 Protein/genetics , NLR Family, Pyrin Domain-Containing 3 Protein/metabolism , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/drug therapy , MAP Kinase Signaling System , Pyroptosis , Blood Glucose/metabolism , Insulin , Glucose , Sodium
2.
Carbohydr Polym ; 264: 117997, 2021 Jul 15.
Article in English | MEDLINE | ID: mdl-33910732

ABSTRACT

Bioinspired from adhesion behaviors of mussels, we first reported a new strategy to prepare catechol-functionalized chitosan (C-CS)/polyvinyl alcohol (PVA) composite films via a solution blending method in neutral aqueous solution for active food packaging. Compared with pure PVA film, the UV transmittance (at 280 nm) of C-CS/PVA composite films decreases by 67.6 % when C-CS content reaches 10 wt%. Still, all the C-CS/PVA composite films are transparent in the visible range. The maximal tensile strength and elongation at break of C-CS/PVA composite films can reach 45.2 MPa and 153 % respectively, which are 46.3 % and 25.4 % higher than those of pure PVA film. The incorporation of C-CS into PVA matrix increases the antibacterial properties significantly. The water resistance of C-CS/PVA composite films can not be significantly deteriorated by the appropriate amount of C-CS. Therefore, C-CS/PVA composite films show great potential in the field of active packaging due to its good mechanical, antibacterial and UV barrier properties.


Subject(s)
Anti-Bacterial Agents/chemistry , Catechols/chemistry , Chitosan/chemistry , Food Packaging/methods , Polyvinyl Alcohol/chemistry , Anti-Bacterial Agents/pharmacology , Catechols/pharmacology , Chitosan/pharmacology , Escherichia coli/drug effects , Humans , Nanocomposites/chemistry , Polyvinyl Alcohol/pharmacology , Solubility , Spectroscopy, Fourier Transform Infrared/methods , Tensile Strength , Ultraviolet Rays
3.
ACS Appl Mater Interfaces ; 13(9): 11524-11534, 2021 Mar 10.
Article in English | MEDLINE | ID: mdl-33635048

ABSTRACT

Tribofilm configuration under the boundary lubrication region is an essential concern to gain insight into the tribological enhancement of the two-dimensional (2D) nano materials toward base oils. In this work, several alkyl carboxylic acids modified 2D triazine-based covalent organic frameworks (ATC) nano platelets were fabricated and served as lubrication additives. When carbon atoms add up to 16, the best lubricating performance is exhibited at an additive concentration of 0.05 wt % and the friction coefficient and wear volume are, respectively, reduced by 56.0% and 89.6% as compared to those of pure PAO 10 base oil. The analysis of the focused ion beam-transmission electron microscope (FIB-TEM) on the worn surface reveals that an alternately multilayer tribofilm consisting of 2D platelet additives and oxides and/or metallic soap salts is formed on the frictional interface of steel substrate, with a well-ordered arrangement along the sliding direction, which dominates the contributions of the excellent lubrication.

4.
Materials (Basel) ; 13(9)2020 Apr 27.
Article in English | MEDLINE | ID: mdl-32349266

ABSTRACT

Poly(lactic acid) (PLA) represents one of the most promising and attractive bio-based polymers for green packaging. However, toughness, gas barrier and antibacterial properties of pure PLA films cannot compete with those of traditional petroleum-based active packaging plastics. To fill this gap, utilization of excellent chelating properties of phytic acid (PA), functionalized layered double hydroxides (LDHs@PA-Cu(II)) was firstly synthetized via facile deposition and chelation of one-step assembled PA-Cu(II) coordination compounds on the surface of layered clay. Furthermore, LDHs@PA-Cu(II)/PLA nanocomposites were prepared by blending LDHs@PA-Cu(II) and pure PLA via solution casting evaporation process. After adding only 1 wt % LDHs@PA-Cu(II), elongation at break and tensile strength increase by 53.0% and 18.9%, respectively, and the oxygen relative permeability decreases by 28.0%. Due to the strong interface interaction and heterogenous nucleation, the reinforcement effect of LDHs@PA-Cu(II) at low loadings is remarkable. Meanwhile, owing to the antibacterial activity of PA-Cu(II) coatings, the antibacterial rate (against Escherichia coli) of LDHs@PA-Cu(II) exceeds 99.99%. Furthermore, the corresponding LDHs@PA-Cu(II)/PLA nanocomposites also show outstanding antibacterial properties, which will be a promising candidate for active packaging application.

SELECTION OF CITATIONS
SEARCH DETAIL